- Acasti Pharma Inc KOL Event TranscriptOct 11, 2023
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptOct 10, 2023
- Acasti Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Acasti Pharma Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q3 2023 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2023C$0.83 (-1.19%)Earnings
- Acasti Pharma Inc GTX-101 and GTX-102 Call TranscriptJan 10, 2023
- Q2 2023 Acasti Pharma Inc Earnings Call TranscriptNov 14, 2022C$0.63 (-3.08%)Earnings
- Q1 2023 Acasti Pharma Inc Earnings Call TranscriptAug 11, 2022C$1.15 (+3.60%)Earnings
- Q4 2022 Acasti Pharma Inc Earnings Call TranscriptJun 21, 2022C$1.22 (+0.83%)Earnings
- Acasti Pharma Inc Announces Positive Results for Pharmacokinetic Bridging Study Call TranscriptMay 18, 2022
- Acasti Pharma Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q3 2022 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2022C$1.58 (+4.64%)Earnings
- Q2 2022 Acasti Pharma Inc Earnings Call TranscriptNov 10, 2021C$2.06 (-1.90%)Earnings
- Acasti Pharma Inc Planned Acquisition of Grace Therapeutics Inc Call TranscriptAug 04, 2021
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptSep 30, 2020
- Q4 2020 Acasti Pharma Inc Earnings Call TranscriptJun 29, 2020C$5.28 (-13.16%)Earnings
- Q3 2020 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2020C$6.08Earnings
- Q2 2020 Acasti Pharma Inc Earnings Call TranscriptNov 13, 2019C$21.76 (-4.23%)Earnings
- Q1 2020 Acasti Pharma Inc Earnings Call TranscriptAug 14, 2019C$21.76 (+7.09%)Earnings
- Q4 2019 Acasti Pharma Inc Earnings Call TranscriptJun 26, 2019C$12.24 (+7.75%)Earnings
Q4 2019 Acasti Pharma Inc Earnings Call Transcript
Greetings, and welcome to the Acasti Pharma Fourth Quarter and Year-end Fiscal 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, David Waldman, with Crescendo Communication. Please go ahead, sir.
Thank you, Kevin. Good afternoon, everyone, and welcome to Acasti Pharma's Fourth Quarter and Fiscal 2019 Conference Call. On the call with us this afternoon are Jan D' Alvise, President and CEO; Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; Brian Groch, Chief Commercial Officer; and Jean-François Boily, Vice President, Finance.
If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.
I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)